Wegovy digestive side effects: what the trial data shows and what to watch for

What the STEP 1 trial data actually recorded

The STEP 1 trial randomised 1,961 adults with obesity and followed them for 68 weeks. Gastrointestinal events were the leading category of side effects: nausea affected roughly 44% of participants on semaglutide compared with around 16% on placebo; vomiting, diarrhoea and constipation each appeared at meaningfully higher rates in the active group too. These figures are worth sitting with. They do not mean that nearly half of everyone who takes Wegovy feels sick throughout treatment. The trial captured any GI event across the entire 68 weeks, including the early weeks of dose titration when symptoms are at their peak. Most events were recorded as mild or moderate in intensity, and the rate fell as participants reached and settled on their maintenance dose. The NHS semaglutide page reflects the same profile: nausea is common, but usually temporary. If you want to understand what to expect right at the beginning of treatment, our guide to side effects at the 0.5 mg starting dose covers what most people encounter during those first weeks before any dose increase. Knowing that the arc bends toward tolerance is genuinely useful rather than a platitude, because it changes how you interpret the first fortnight.

Why semaglutide causes these digestive symptoms

Semaglutide activates GLP-1 receptors in the gut as well as the brain. One effect is a slowing of gastric emptying: food moves through the stomach more slowly than it otherwise would. That is partly why appetite falls and fullness arrives sooner, but it is also why nausea, bloating, burping and reflux are common companions, especially early on. Constipation, by contrast, tends to reflect slower overall gut transit. Diarrhoea can occur too, often in the early weeks, and appears to be dose-related, it is more likely immediately after a step up. The NHS guidance on semaglutide advises eating smaller portions, avoiding rich or fatty meals, and staying well hydrated as practical ways to reduce the burden. Eating slowly, pausing between bites, and not lying down immediately after meals are also commonly suggested. None of this replaces guidance from your own prescriber, who can advise based on your specific pattern of symptoms. If side effects are making the medicine very difficult to tolerate, the titration pace can sometimes be adjusted, that conversation belongs with your clinical team. Our broader Wegovy side effects page covers non-digestive effects alongside these.

When to get medical help

Most digestive discomfort from Wegovy is self-limiting, but two categories of symptoms need prompt attention and should not be waited out. First, severe stomach pain that persists and extends to the back (with or without vomiting) can be a sign of acute pancreatitis. In January 2026, the MHRA issued a Drug Safety Update highlighting pancreatitis as a known though infrequent risk with GLP-1 medicines, and stressing that this symptom pattern warrants urgent medical assessment. Do not take paracetamol and hope it passes: contact NHS 111 or go to A&E. Second, repeated vomiting or severe diarrhoea can cause dehydration quickly, which in turn puts pressure on the kidneys. Signs of significant dehydration (dizziness on standing, very dark urine, confusion, inability to keep any fluids down) also need same-day clinical review. Any suspected allergic reaction (swelling of the face or throat, difficulty breathing) is a 999 call. For context on what counts as a more typical settling-in symptom versus a signal that needs review, a dedicated page on indigestion and Wegovy goes into more detail on that specific symptom.

Side effects in context: who tolerates Wegovy well and how the consultation helps

Not everyone experiences significant digestive side effects. A proportion of people starting Wegovy notice very little gut disruption at all, and if you are curious about that picture, our page on starting Wegovy with minimal side effects covers what the data says. There are also beneficial effects some people notice alongside the main weight-loss outcome. The question of whether Wegovy is appropriate for you (including how your personal medical history, any other medicines you take, and your GI history might affect tolerability) is exactly what a clinical consultation exists to answer. At nume, a GPhC-registered Independent Prescriber reads every consultation personally, the same day it is submitted. If it is clinically suitable for you to start, treatment can be dispatched the same day for free next-working-day delivery by DPD, arriving before the school run if you order by 12pm on a weekday. Aftercare is available seven days a week if questions arise once you begin. You can read more about how Wegovy works or explore all available weight-loss treatment options at nume, and our clinical team is the right place to take any specific questions about your own suitability.